- Home
- AZN vs CRWD Comparison
AZN vs CRWD Comparison
Compare AZN & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AZN | CRWD |
|---|---|---|
| Founded | 1992 | 2011 |
| Country | United Kingdom | United States |
| Employees | 96100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.4B | 165.5B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | AZN | CRWD |
|---|---|---|
| Price | $177.97 | $680.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 48 |
| Target Price | N/A | ★ $507.00 |
| AVG Volume (30 Days) | 1.9M | ★ 3.3M |
| Earning Date | 04-29-2026 | 06-02-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $4,812,005,000.00 |
| Revenue This Year | $10.34 | $24.85 |
| Revenue Next Year | $6.43 | $21.40 |
| P/E Ratio | ★ $31.91 | $6,191.64 |
| Revenue Growth | N/A | ★ 21.71 |
| 52 Week Low | $68.62 | $342.72 |
| 52 Week High | $212.71 | $785.66 |
Technical Indicators
Market Signals| Indicator | AZN | CRWD |
|---|---|---|
| Relative Strength Index (RSI) | 43.36 | 57.55 |
| Support Level | $174.60 | $456.60 |
| Resistance Level | $191.50 | $785.66 |
| Average True Range (ATR) | 3.11 | 37.10 |
| MACD | -0.16 | -10.71 |
| Stochastic Oscillator | 31.44 | 37.24 |
Price Performance
Historical ComparisonAbout AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
About CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.